Skip to main content

Table 1 Clinical characteristics of patients included in the survival analysis

From: Genotype-phenotype correlations among BRCA14153delA and 5382insC mutation carriers from Latvia

Variable c.4034delA c.5266dupC Control
N. of patients 25 68 103
Median age of onset (years) 51.7 46.5 54.9
T4 - n. (%) 5 (20%) 10 (15%) 7 (7%)
T3 - n. (%) 1 (4%) 3 (4%) 13 (13%)
T2 - n. (%) 14 (56%) 43 (63%) 63 (61%)
T1 - n. (%) 5 (20%) 12 (18%) 20 (19%)
Axillary node positive - n. (%) 14 (56%) 32 (47%) 44 (43%)
ER/PR positive (%) 50% 15% 70%
HER2 positive (%) 22% 11% 10%
ER/PR/HER2 (Triple) negative (%) 50% 79% 24%
N. of patients dead from cancer during follow-up period 9 (36%) 15 (22%) 21 (20%)